Articles

Poll

Podcasts

Slideshows

Videos

Allergy

Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.

Innovative therapies and devices are transforming food allergy management, enhancing safety and quality of life for patients and families.

A New Era in Food Allergy Treatment: The Push Toward Multi-Allergen Immunotherapy

DBV Technologies announced that the phase 3 VITESSE trial on VIASKIN® Peanut patch for peanut-allergic children met its primary endpoint.

VIASKIN Peanut Patch Effective in Peanut-Allergic Children Aged 4–7 Years

Study finds eczema onset at 4–6 months, greater severity, and longer duration linked to lower odds of outgrowing food allergies in children.

Eczema Onset at 4 Months May Reduce the Chance of Outgrowing Food Allergies

At ACAAI 2025, Gross outlined new food allergy ICD-10 codes, clarified documentation rules, and shared tips to help allergists prevent claim denials.


ICD-10, CPT Updates for 2025: What Allergists Need to Know, With Gary Gross, MD

HCPLive spoke with Al Ali at ACAAI 2025 about a study comparing the safety of protocols for milk and peanut allergens.

Baked Milk, Peanut OIT Reduced Systemic Reactions by 35%, With Adnan Al Ali, MD, PhD

A preview of 5 slated expert interviews and 5 late-breaking clinical trials to watch out for at ACAAI 2025.

ACAAI 2025 Conference Preview: 5 Trials to Watch Out For  

This month in review spotlights 6 top allergy stories, from falling peanut allergy rates to intranasal steroid cream easing post-surgical rhinosinusitis.

6 Allergy Headlines You Missed in October 2025

Gabryszewski said new data confirm early introduction guidelines are working, showing real-world declines in peanut allergy. 

Peanut Allergy Decline Shows Success of Early Introduction Guidelines, With Stanislaw J. Gabryszewski, MD, PhD

New data show peanut allergy rates have dropped sharply since early introduction guidelines, reducing 27% and 43% after the 2015 and 2017 guidelines, respectively.


Peanut Allergy Rates Plummet 10 Years After AAP Early Introduction Guidelines

Explore the latest advancements in allergy and immunology, including new therapies, FDA approvals, and innovative clinical strategies for improved patient care from Q3.